CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $169,000 | +19.9% | 40,437 | +132.2% | 0.00% | – |
| Q3 2021 | $141,000 | -78.0% | 17,413 | -79.5% | 0.00% | -100.0% |
| Q2 2021 | $641,000 | -38.8% | 84,927 | -29.7% | 0.00% | -50.0% |
| Q1 2021 | $1,048,000 | +7.4% | 120,786 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $976,000 | -5.2% | 122,424 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $1,029,000 | +1219.2% | 129,042 | +732.5% | 0.00% | – |
| Q3 2019 | $78,000 | -55.7% | 15,501 | -41.6% | 0.00% | – |
| Q2 2019 | $176,000 | -29.0% | 26,558 | -18.9% | 0.00% | – |
| Q1 2019 | $248,000 | -6.4% | 32,737 | 0.0% | 0.00% | – |
| Q4 2018 | $265,000 | -37.2% | 32,737 | 0.0% | 0.00% | – |
| Q3 2018 | $422,000 | +13.1% | 32,737 | 0.0% | 0.00% | – |
| Q2 2018 | $373,000 | +145.4% | 32,737 | +32.5% | 0.00% | – |
| Q2 2015 | $152,000 | – | 24,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |